Page last updated: 2024-12-06

pentaethylene glycol monododecyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pentaethylene glycol monododecyl ether: structure given in first source; a non-ionic surfactant [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

laureth-5 : A hydroxypolyether that is pentaethylene glycol in which one of the terminal hydrogens is replaced by a dodecyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID18281
CHEBI ID91323
SCHEMBL ID61729
MeSH IDM0207062

Synonyms (42)

Synonym
laureth-5
pentaethylene glycol monododecyl ether
pentaoxyethylene monododecyl ether
lauryl alcohol tetra(oxyethylene) ethanol
peg-5 lauryl ether
pentaethylene glycol lauryl ether
pentaethylene glycol dodecyl ether
einecs 221-281-8
3,6,9,12,15-pentaoxaheptacosan-1-ol
pentaethylene glycol monododecyl ether, bioxtra, >=98.0% (gc)
2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethanol
P0372
3055-95-6
q9f4a7xye8 ,
unii-q9f4a7xye8
c12e5
SCHEMBL61729
CHEBI:91323 ,
DTXSID1058632
pentaethylene glycol mono-n-dodecyl ether
mulsifan rt 23
LAPRIVJANDLWOK-UHFFFAOYSA-N
mfcd00043064
AKOS025402723
J-018012
dodecyl pentaethylene glycolether
ce;pentaethyleneglycolmonododecylether
FT-0752925
Q3899231
CS-0204266
pentaoxyethylene glycol mono-n-dodecyl ether
safol 23e5 ethoxylate
dodecyl penta(ethylene oxide)
monododecyl pentaethylene glycol
ethanol, 2-(2-(2-(2-(2-(dodecyloxy)ethoxy)ethoxy)ethoxy)ethoxy)-
intrasol fa 12/18/5
c12eo5
n-dodecyl pentaoxyethylene monoether
AMY22507
T72264
pentaethyleneglycolmonododecylether
alpha-dodecyl-omega-hydroxypentakis(oxyethylene)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
nonionic surfactantA surfactant with an uncharged hydrophilic headgroup.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
hydroxypolyetherA hydroxyether compound containing more than one ether group.
pentaethylene glycol
primary alcoholA primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (9.52)18.2507
2000's9 (42.86)29.6817
2010's9 (42.86)24.3611
2020's1 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.55 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]